Company Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system.
It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body.
In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data.
The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008.
Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
| Country | United States |
| Founded | 2006 |
| IPO Date | Nov 14, 2013 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 2,400 |
| CEO | John F. Sheridan |
Contact Details
Address: 12400 High Bluff Drive San Diego, California 92130 United States | |
| Phone | 858-366-6900 |
| Website | tandemdiabetes.com |
Stock Details
| Ticker Symbol | TNDM |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001438133 |
| CUSIP Number | 875372203 |
| ISIN Number | US8753722037 |
| Employer ID | 20-4327508 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| John F. Sheridan | President, Chief Executive Officer and Director |
| Leigh A. Vosseller | Executive Vice President, Chief Financial Officer and Treasurer |
| Susan M. Morrison | Executive Vice President and Chief Administrative Officer |
| David B. Berger Esq. | Transitional Advisor |
| Brian B. Hansen | Executive Officer |
| Elizabeth Anne Gasser | Executive Vice President and Chief Strategy and Product Officer |
| Rick A. Carpenter | Chief Technical Officer |
| Shannon M. Hansen | Executive Vice President, Chief Legal, Privacy and Compliance Officer and Secretary |
| Tom Fox | Chief Human Resources Officer |
| Dr. Jordan Pinsker M.D. | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 9, 2024 | ARS | Filing |
| Apr 9, 2024 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 9, 2024 | DEF 14A | Other definitive proxy statements |
| Apr 1, 2024 | 8-K | Current Report |
| Mar 11, 2024 | 8-K | Current Report |
| Feb 21, 2024 | 10-K | Annual Report |
| Feb 21, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |